SCHEMBL28970122

SCHEMBL28970122

CC1Cc2[nH]ncc2CN1C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.48
NAMPT P43490 1/20 0.45
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ACACB O00763 2/20 0.38
PSEN1 P49768 4/20 0.37
PSEN2 P49810 4/20 0.37
APH1B Q8WW43 4/20 0.37
NCSTN Q92542 4/20 0.37
APH1A Q96BI3 4/20 0.37
PSENEN Q9NZ42 4/20 0.37
PDK2 Q15119 2/20 0.36
PTPN1 P18031 2/20 0.35
MAPK1 P28482 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
UCHL1 P09936 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34469116 1.00 NR1H2 (0.48) NR1H2NAMPTMEN1KMT2AACACB
SCHEMBL3061206 0.81 PSEN1 (0.48) NR1H2NAMPTMEN1KMT2APSEN1
SCHEMBL30895177 0.80 NR1H2 (0.49) NR1H2NAMPTMEN1KMT2AACACB
SCHEMBL6890800 0.78 NR1H2 (0.62) NR1H2NAMPTACACBPSEN1PSEN2
SCHEMBL29385334 0.76 MEN1 (0.39) NR1H2NAMPTMEN1KMT2APTPN1
SCHEMBL23794828 0.76 NR1H2 (0.39) NR1H2NAMPTMEN1KMT2AACACB
SCHEMBL26260560 0.76 NR1H2 (0.39) NR1H2NAMPTMEN1KMT2AACACB
SCHEMBL34469262 0.75 MEN1 (0.41) NR1H2MEN1KMT2APTPN1GPR119
SCHEMBL23868265 0.75 MEN1 (0.39) NR1H2MEN1KMT2APTPN1MAPK1
SCHEMBL1018783 0.75 NR1H2 (0.58) NR1H2NAMPTACACBPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115806561-A JAK3 selective inhibitors and uses thereof 南京药石科技股份有限公司 2023-03-17 CN disclosed
CN-114057739-A Diazepinone derivatives and their use in the treatment of hepatitis b infections 诺维拉治疗公司 2022-02-18 CN disclosed